Title 19 Promis - Jul 25, 2025 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
10%+ Owner
Signature
Title 19 Promis By: /s/ Michael S. Gordon, Manager
Stock symbol
PMN
Transactions as of
Jul 25, 2025
Transactions value $
$0
Form type
4
Date filed
7/29/2025, 08:18 PM
Previous filing
Aug 2, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Title 19 Promis 10%+ Owner C/O TROVE,, 40 BROAD STREET, 8TH FLOOR, BOSTON Title 19 Promis By: /s/ Michael S. Gordon, Manager 2025-07-29 0002005531
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMN Common Shares, no par value Exercise of in-the-money or at-the-money derivative security +120K +5.77% 2.2M Jul 25, 2025 Direct F1
transaction PMN Common Shares, no par value Exercise of in-the-money or at-the-money derivative security +120K +5.46% 2.32M Jul 25, 2025 Direct F2
transaction PMN Common Shares, no par value Exercise of in-the-money or at-the-money derivative security +120K +5.17% 2.44M Jul 25, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Tranche A Common Share Purchase Warrants Exercise of in-the-money or at-the-money derivative security $0 -120K -25.76% $0.00 345K Jul 25, 2025 Common Shares 120K Direct F1
transaction PMN Tranche B Common Share Purchase Warrants Exercise of in-the-money or at-the-money derivative security $0 -120K -25.76% $0.00 345K Jul 25, 2025 Common Shares 120K Direct F2
transaction PMN Tranche C Common Share Purchase Warrants Exercise of in-the-money or at-the-money derivative security $0 -120K -25.76% $0.00 345K Jul 25, 2025 Common Shares 120K Direct F3
transaction PMN Warrants to Purchase Common Shares Purchase +539K 539K Jul 29, 2025 Common Shares 539K Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 25, 2025, Title 19 Promis exercised 119,800 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by Title 19 Promis and an acceptance by the Issuer, were exercised at an exercise price of $0.83158 per share. The remainder of these warrants are currently exercisable and expire on the earlier of (i) 18 months of the issue date and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 6-month data from the cohorts treated with single ascending doses of PMN310.
F2 On July 25, 2025, Title 19 Promis exercised 119,800 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by Title 19 Promis and an acceptance by the Issuer, were exercised at an exercise price of $0.83158 per share. The remainder of these warrants are currently exercisable and expire on the earlier of (i) 30 months of the issue date and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 12-month data from the cohorts treated with single ascending doses of PMN310.
F3 On July 25, 2025, Title 19 Promis exercised 119,800 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by Title 19 Promis and an acceptance by the Issuer, were exercised at an exercise price of $0.83158 per share. The remainder of these warrants are currently exercisable and expire on July 31, 2029.
F4 On July 29, 2025, Title 19 Promis acquired 539,100 warrants, each exercisable to purchase one Common Share, at an exercise price of $1.25 per share. The purchase price for each warrant was $0.1875 per share. The warrants are currently exercisable and expire five years after the date of issuance.